FDA advisory panel backs approval of Grail Galleri cancer screening test - GRAL News | RalliesFDA advisory panel backs approval of Grail Galleri cancer screening test
G
GRAL• Advisory panel backs Galleri approval
- FDA advisory panel backed approval of Grail’s Galleri multi-cancer early detection blood test for adults aged 50 and older.
- Panel voted 7-2, with 1 abstention, that benefits outweigh risks; safety vote was unanimous; effectiveness vote was 6-4.
- FDA final decision on the PMA is expected in the coming months.
ALNT
•
